Role of regulatory 622 subunits and protein kinase inhibitor (PKI) in determining nuclear localization and 623 activity of the catalytic subunit of protein kinase A, J Biol Chem, vol.274, pp.6381-6388, 1999. ,
, , p.625
, , p.626
, , p.627
A genome-wide scan 628 identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in 629 individuals with adrenocortical hyperplasia, Nat Genet, vol.38, pp.794-800, 2006. ,
, , p.631
, , p.632
A cAMP-specific phosphodiesterase (PDE8B) that is mutated in 633 adrenal hyperplasia is expressed widely in human and mouse tissues: a novel PDE8B 634 isoform in human adrenal cortex, Eur J Hum Genet, vol.16, pp.1245-53, 2008. ,
MAP kinase activity increases during mitosis in 636 early sea urchin embryos, J Cell Sci, vol.111, pp.2497-505, 1998. ,
Synergistic 638 inhibition of APC/C by glucose and activated Ras proteins can be mediated by each of 639 the Tpk1-3 proteins in Saccharomyces cerevisiae, Microbiology, vol.149, pp.1205-1221, 2003. ,
Cyclic AMP delays G2 progression and prevents 641 efficient accumulation of cyclin B1 proteins in mouse macrophage cells, Cell Struct 642 Funct, vol.23, pp.357-65, 1998. ,
, , p.644
Regulation of cAMP on the first mitotic cell cycle of mouse embryos, p.645, 2008. ,
, Mol Reprod Dev, vol.75, pp.489-95
Signalling pathways involved in the mitogenic effects of cAMP, p.647, 1997. ,
, Clin Sci (Lond), vol.92, pp.445-51
The spatio-temporal dynamics of PKA activity profile during 650 mitosis and its correlation to chromosome segregation, Cell Cycle, vol.13, pp.3232-3272, 2014. ,
, , 2001.
, Type I protein kinase a is localized to interphase microtubules and strongly associated 653 with the mitotic spindle, Exp Cell Res, vol.264, pp.250-65
, , p.655
, GNAS mutations in adrenal aldosterone-producing adenomas, p.657, 2016.
, Endocr J, vol.63, pp.199-204
The Many Faces of Primary Aldosteronism and Cushing 659 Syndrome: A Reflection of Adrenocortical Tumor Heterogeneity, Front Med, vol.660, issue.5, p.54, 2018. ,
Novel Insights into the 662 Genetics and Pathophysiology of Adrenocortical Tumors, Front Endocrinol, vol.663, issue.6, p.96, 2015. ,
PRKACA mutations in adrenal Cushing can alter substrate specificity, Endocrine Abstracts, p.665, 2017. ,
Alterations in Protein Kinase A Substrate 666 Specificity as a Potential Cause of Cushing Syndrome, Endocrinology, vol.160, pp.447-459, 2019. ,
cAMP-668 dependent protein kinase activation inhibits proliferation and enhances apoptotic 669 effect of tumor necrosis factor-alpha in NCI-H295R adrenocortical cells, J Mol 670 Endocrinol, vol.33, pp.511-533, 2004. ,
, , p.672
, , p.673
Mutations of beta-catenin in adrenocortical tumors: 674 activation of the Wnt signaling pathway is a frequent event in both benign and 675 malignant adrenocortical tumors, Cancer Res, vol.65, pp.7622-7629, 2005. ,
, , p.677
Transcriptome 678 analysis reveals that p53 and {beta}-catenin alterations occur in a group of aggressive 679 adrenocortical cancers, Cancer Res, vol.70, pp.8276-81, 2010. ,
, , p.681
RIalpha influences cellular proliferation in cancer cells by transporting 682 RFC40 into the nucleus, Cancer Biol Ther, vol.4, pp.429-466, 2005. ,
Specificity and spatial dynamics of protein kinase A 684 signaling organized by A-kinase-anchoring proteins, J Mol Endocrinol, vol.44, pp.271-84, 2010. ,
, , p.686
Isoform-specific targeting of PKA to 687 multivesicular bodies, J Cell Biol, vol.193, pp.347-63, 2011. ,
The PKARIalpha 689 subunit of protein kinase A modulates the activation of p90RSK1 and its function, J 690 Biol Chem, vol.284, pp.23670-81, 2009. ,
, , p.692, 2006.
, Subcellular localization and biological actions of activated RSK1 are determined by 693 its interactions with subunits of cyclic AMP-dependent protein kinase, Mol Cell Biol, vol.694, pp.4586-600